Solid Growth Predicted for Australia’s X-Ray Systems Sector

Australia’s medical imaging landscape is undergoing a transformative shift as artificial intelligence (AI) redefines diagnostic accuracy in chest X-rays. By integrating clinical data with imaging, AI is enabling diseases such as pneumonia, lung cancer, and tuberculosis to be detected earlier.

Consequently, the country’s X-ray systems market is expected to grow 4% annually through 2036, according to GlobalData. Its latest report, “X-Ray Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036,” reveals that Australia accounted for nearly 2% of the Asia-Pacific (APAC) X-ray systems market last year. This share is expected to have a promising rise as healthcare providers increasingly adopt AI tools to enhance diagnostic precision, reduce radiologist workload, and improve patient outcomes.

National science agency CSIRO’s Australian e-Health Research Centre has recently developed a breakthrough approach that enables AI to produce more accurate chest X-ray reports by incorporating the same clinical information used by doctors. By combining imaging data with emergency department records-including vital signs, medication history, and clinical notes, researchers have improved the AI’s diagnostic performance.

“The use of AI in interpreting chest X-rays marks a significant advancement in diagnostic abilities. This can identify minor issues such as early-stage pneumonia, lung cancer, or tuberculosis, which might be missed during conventional readings,” GlobalData Medical Devices Analyst Prerna Gupta said. “This is particularly beneficial in rural and underprivileged regions where there is a shortage of specialized radiologists.”

In addition, regulatory approvals from the Therapeutic Goods Administration (TGA) are enabling faster integration of advanced solutions into clinical workflows. With ongoing collaborations between hospitals, universities, and AI developers, the accuracy and speed of AI-driven chest X-ray readings are improving significantly.

“The growing confidence of clinicians in AI-assisted diagnostics, coupled with strategic investments from both the public and private sectors, is expected to accelerate adoption in the coming years,” Gupta stated. “This momentum suggests a strong pipeline of innovation and potential investment opportunities in Australia’s medical imaging market.”